期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 112, 期 45, 页码 14078-14083出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1512812112
关键词
neurodegenerative; basal ganglia; movement disorder; trinucleotide repeat disorder
资金
- National Institutes of Health [U01MH067965]
- National Institute of Neurological Disorders and Stroke [R01 NS065867]
- National Institute of Mental Health [5P56-NS071669]
- NIH/National Institute of Environmental Health Sciences [R01 ES016931]
Mutations that lead to Huntington's disease (HD) result in increased transmission at glutamatergic corticostriatal synapses at early pre-symptomatic stages that have been postulated to set the stage for pathological changes and symptoms that are observed at later ages. Based on this, pharmacological interventions that reverse excessive corticostriatal transmission may provide a novel approach for reducing early physiological changes and motor symptoms observed in HD. We report that activation of the M-4 subtype of muscarinic acetylcholine receptor reduces transmission at corticostriatal synapses and that this effect is dramatically enhanced in presymptomatic YAC128 HD and BACHD relative to wild-type mice. Furthermore, chronic administration of a novel highly selective M-4 positive allosteric modulator (PAM) beginning at presymptomatic ages improves motor and synaptic deficits in 5-mo-old YAC128 mice. These data raise the exciting possibility that selective M-4 PAMs could provide a therapeutic strategy for the treatment of HD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据